Zentek successfully completes Phase 2 Results of HVAC Testing

The report notes a significant reduction in live airborne test organisms with ZenGUARD™ coating applied to standard HVAC filters.

Zentek Ltd., one of the leading intellectual property development and commercialisation company, reports, the successful completion of Phase 2 HVAC filter testing by the National Research Council of Canada (“NRC”).

The company has received the preliminary report from Phase 2 testing under its Innovative Solutions Canada (“ISC”) Testing Stream contract. The report notes a significant reduction in live airborne test organisms with ZenGUARD™ coating applied to standard HVAC filters without modification to existing HVAC systems, with no reduction in air flow rates or increasing energy use. The testing demonstrated a reduction in live airborne bacteriophage surrogate contamination within a modular classroom environment, simulating a real-world environment. The testing was performed at the NRC’s unique bioaerosol testing facility designed and built specifically for testing wet aerosolised droplets, which is the primary mechanism for the spread of disease in an indoor setting.

Greg Fenton, CEO, Zentek, said, “The significant increase in filtration efficiency of pathogen-laden water droplets without an impact to airflow rates creates a potentially powerful solution in the HVAC space. We are pleased that our patented ZenGUARD™ solution has shown to be effective and which could provide commercial opportunities to a wide array of indoor environmental stakeholders to improve air quality. From governments, schools, homeowners and hospitals to real estate management companies, landlords and tenants alike, all could utilise their existing equipment without additional capital investment, maintenance, or energy costs – enabling a simple and elegant solution. The result of providing cleaner air for indoor spaces is consistent with current global indoor air quality initiatives and environmental goals of reducing energy consumption.”

Ryan Shacklock, VP of Strategy and Business Development at Zentek, said, “The results of the National Research Council of Canada’s Phase 2 testing help validate our business model. Along with our Health Canada-authorised ZenGUARD™-coated surgical masks, which demonstrated 99.99 percent Viral and Bacterial Filtration Efficacy, these HVAC test results bring us closer to the commercialisation of our second ZenGUARD™-based product. ZenGUARD™ is becoming an antimicrobial technology platform from which we can potentially generate multiple other products that help improve air quality, health and safety.”

The company’s next steps towards commercialisation is to continue to work to optimise configurations of HVAC filter materials coated with patented technology at LMS to optimise our product offerings. To complete all testing, and documentation required for regulatory submissions in Canada and the United States. The company has hired Intertek Group plc to conduct a review of regulatory requirements in other geographies of interest.